Literature DB >> 32257207

Association between functional TERT promoter polymorphism rs2853669 and cervical cancer risk in South Indian women.

Vilvanathan Vinothkumar1, Kanagaraj Arun1, Ganesan Arunkumar1, Sundaramoorthy Revathidevi1, Rajendren Ramani2, Lakkakula V K S Bhaskar3, Avaniyapuram Kannan Murugan4, Arasambattu Kannan Munirajan1.   

Abstract

A single nucleotide polymorphism (SNP) rs2853669 (A>G) in the telomerase reverse transcriptase (TERT) promoter has recently been reported in chr5:1,295,349 T>C (T349C), and was shown to be associated with increased cancer risk and poor survival in a specific population. However, at present, the role of this particular SNP with TERT promoter driver mutations and its genetic association with human papilloma virus (HPV) in patients with cervical cancer has not been determined. In the present study, the genetic association of the functional SNP rs2853669 in the presence/absence of TERT promoter hotspot mutations and HPV in patients with cervical cancer of South Indian origin was evaluated. To understand and compare the frequency of the variant allele and its risk association in different cancer types of various populations, the SNP was genotyped in 257 cervical cancer samples and 295 controls, and its associations with TERT promoter hotspot mutations and HPV were analyzed. Furthermore, an extensive search of previously published articles in PubMed, Embase and Web of Science was conducted; a meta-analysis was carried out to elucidate the association of the SNP with different cancer types in global populations. The SNP analysis showed significantly high frequency (41%) of homozygous variant allele rs2853669 (GG) in patients with cervical cancer compared with control samples [Recessive allele model odds ratio (OR)=1.71; 95% CI=1.20-2.43; P=0.003]. No significant interaction was observed between the TERT SNP rs2853669 and HPV status as well as other hotspot TERT promoter (C228T and C250T) mutations determined in our previous study. In addition, the overall meta-analysis revealed a significant association of the SNP rs2853669 with other cancer types in different ethnic populations (OR=1.09; 95% CI=1.03-1.16; P=0.004). The present results suggested that the TERT SNP rs2853669 could play an important role in the risk of cervical cancer in a South Indian population.
Copyright © 2019, Spandidos Publications.

Entities:  

Keywords:  cervical cancer; human papilloma virus; polymorphism; promoter single nucleotide polymorphism; rs2853669; telomerase reverse transcriptase

Year:  2020        PMID: 32257207      PMCID: PMC7087481          DOI: 10.3892/mco.2020.2003

Source DB:  PubMed          Journal:  Mol Clin Oncol        ISSN: 2049-9450


  5 in total

Review 1.  Human TERT promoter polymorphism rs2853669 is associated with cancers: an updated meta-analysis.

Authors:  Md Abdul Aziz; Sarah Jafrin; Mohammad Safiqul Islam
Journal:  Hum Cell       Date:  2021-03-20       Impact factor: 4.174

2.  Association Between Potentially Functional Variants in chr5q14 and the Risk of Cervical Cancer in a Chinese Population.

Authors:  Yuqing Liu; Ling Mei; Yueyue Chen; Xiaoli Zhang; Dongmei Wei; Tao Cui; Yueting Zhang; Tao Wang; Xiaoyu Niu
Journal:  Reprod Sci       Date:  2022-07-18       Impact factor: 2.924

Review 3.  TERT-Regulation and Roles in Cancer Formation.

Authors:  Marta Dratwa; Barbara Wysoczańska; Piotr Łacina; Tomasz Kubik; Katarzyna Bogunia-Kubik
Journal:  Front Immunol       Date:  2020-11-19       Impact factor: 7.561

4.  Anchored Multiplex PCR Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA.

Authors:  Russell J Diefenbach; Jenny H Lee; Ashleigh Stewart; Alexander M Menzies; Matteo S Carlino; Robyn P M Saw; Jonathan R Stretch; Georgina V Long; Richard A Scolyer; Helen Rizos
Journal:  Front Oncol       Date:  2022-04-12       Impact factor: 5.738

Review 5.  The Drivers, Mechanisms, and Consequences of Genome Instability in HPV-Driven Cancers.

Authors:  Vanessa L Porter; Marco A Marra
Journal:  Cancers (Basel)       Date:  2022-09-23       Impact factor: 6.575

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.